Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

作者: Schlomo Staszewski , Javier Morales-Ramirez , Karen T. Tashima , Anita Rachlis , Daniel Skiest

DOI: 10.1056/NEJM199912163412501

关键词: Protease inhibitor (pharmacology)VirologySidaLamivudineZidovudineNucleosideRegimenIndinavirEfavirenzMedicinePharmacology

摘要: Background Efavirenz is a nonnucleoside reverse-transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). We compared two regimens containing efavirenz, one with a …

参考文章(40)
Geneviève Chêne, Philippe Morlat, Catherine Leport, Richard Hafner, Laurence Dequae, Isabelle Charreau, Jean-Pierre Aboulker, Benjamin Luft, Jean Aubertin, Jean-Louis Vildé, Roger Salamon, ANRS 005/ACTG 154 Trial Group, Intention-to-Treat vs. On-Treatment Analyses of Clinical Trial Data: Experience from a Study of Pyrimethamine in the Primary Prophylaxis of Toxoplasmosis in HIV-Infected Patients Controlled Clinical Trials. ,vol. 19, pp. 233- 248 ,(1998) , 10.1016/S0197-2456(97)00145-1
Rita Sun, Joanne Ku, Harsha Jayakar, Jo-Chi Kuo, Donald Brambilla, Steven Herman, Maurice Rosenstraus, Joanne Spadoro, Ultrasensitive Reverse Transcription-PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma Journal of Clinical Microbiology. ,vol. 36, pp. 2964- 2969 ,(1998) , 10.1128/JCM.36.10.2964-2969.1998
M. Floridia, R. Bucciardini, D. Ricciardulli, V. Fragola, M. F. Pirillo, L. E. Weimer, C. Tomino, G. Giannini, C. M. Galluzzo, M. Andreotti, A. Cargnel, F. Alberici, B. De Rienzo, F. Leoncini, F. Fiaccadori, D. Francisci, W. Grillone, L. Ortona, M. Piazza, A. Scalzini, E. Nigra, F. Tumietto, S. Vella, A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease. Journal of Acquired Immune Deficiency Syndromes. ,vol. 20, pp. 11- 19 ,(1999) , 10.1097/00042560-199901010-00002
Valerie E. Stone, Jennifer Clarke, Joan Lovell, Kathleen A. Steger, Lisa R. Hirschhorn, Stephen Boswell, Alicia D. Monroe, Michael D. Stein, Tamra J. Tyree, Kenneth H. Mayer, HIV/AIDS patients’ perspectives on adhering to regimens containing protease inhibitors Journal of General Internal Medicine. ,vol. 13, pp. 586- 593 ,(1998) , 10.1046/J.1525-1497.1998.00180.X
Ken P. Kleinman, Joseph G. Ibrahim, Nan M. Laird, A Bayesian framework for intent-to-treat analysis with missing data Biometrics. ,vol. 54, pp. 265- 278 ,(1998) , 10.2307/2534013
Seiichi Hashida, Kazuya Hashinaka, Ichiro Nishikata, Shinichi Oka, Kaoru shimada, Atsushi Saito, Akihisa Takamizawa, Hideo Shinagawa, Eiji Ishikawa, Shortening of the window period in diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgG to p17 and reverse transcriptase in serum with ultrasensitive enzyme immunoassay. Journal of Virological Methods. ,vol. 62, pp. 43- 53 ,(1996) , 10.1016/0166-0934(96)02087-3
J. W. Mellors, C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, L. A. Kingsley, Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma Science. ,vol. 272, pp. 1167- 1170 ,(1996) , 10.1126/SCIENCE.272.5265.1167
Lisa I. Malaty, Jeffrey J. Kuper, Drug interactions of HIV protease inhibitors. Drug Safety. ,vol. 20, pp. 147- 169 ,(1999) , 10.2165/00002018-199920020-00005
Andrew Carr, Stefano Vella, Menno D. de Jong, Franco Sorice, Allison Imrie, Charles A. Boucher, David A. Cooper, A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group. AIDS. ,vol. 10, pp. 635- 641 ,(1996) , 10.1097/00002030-199606000-00009
R. Striker, D. Conlin, M. Marx, L. Wiviott, Localized Adipose Tissue Hypertrophy in Patients Receiving Human Immunodeficiency Virus Protease Inhibitors Clinical Infectious Diseases. ,vol. 27, pp. 218- 220 ,(1998) , 10.1086/517682